1. Home
  2. TGL vs MBRX Comparison

TGL vs MBRX Comparison

Compare TGL & MBRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Treasure Global Inc.

TGL

Treasure Global Inc.

N/A

Current Price

$0.25

Market Cap

5.4M

Sector

Technology

ML Signal

N/A

Logo Moleculin Biotech Inc.

MBRX

Moleculin Biotech Inc.

N/A

Current Price

$9.50

Market Cap

6.4M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
TGL
MBRX
Founded
2020
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Retail: Computer Software & Peripheral Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.4M
6.4M
IPO Year
2022
2016

Fundamental Metrics

Financial Performance
Metric
TGL
MBRX
Price
$0.25
$9.50
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
★ $240.00
AVG Volume (30 Days)
★ 8.9M
412.0K
Earning Date
10-13-2026
11-12-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 51.53
N/A
EPS
N/A
★ N/A
Revenue
★ $5,169,784.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
★ 121.83
N/A
52 Week Low
$0.19
$0.16
52 Week High
$587.80
$15.75

Technical Indicators

Market Signals
Indicator
TGL
MBRX
Relative Strength Index (RSI) 25.57 92.25
Support Level $0.19 $2.12
Resistance Level $3.30 N/A
Average True Range (ATR) 0.19 0.45
MACD 0.02 0.82
Stochastic Oscillator 4.94 97.36

Price Performance

Historical Comparison
TGL
MBRX

About TGL Treasure Global Inc.

Treasure Global Inc has created an online-to-offline e-commerce platform business model that offers consumers and merchants instant rebates and affiliate cashback programs, while providing a seamless e-payment solution with rebates in both e-commerce and physical retail or merchant settings. Its product is an internet application branded as the ZCITY app, which targets consumers by providing personalized deals based on their purchase history, location, and preferences. The Company has two reportable segments: payment processing and e-commerce operation in its ZCITY platform, and customized software development service, and the majority of revenue comes from payment processing and e-commerce operation in its ZCITY platform.

About MBRX Moleculin Biotech Inc.

Moleculin Biotech Inc is a late-stage pharmaceutical development company currently evaluating Annamycin, also known as L-Annamycin and by its generic name naxtarubicin. The company has two additional portfolios of technologies for hard-to-treat cancers and viruses with clinical and preclinical research funded by investigators at academic institutions. The Company operates in one reportable segment, which is the development and commercialization of drug products.

Share on Social Networks: